Edesa Biotech
EDSA | NASDAQ
$1.89
-$0.05 (-2.33%)
At close: Nov 16, 2026, 4:00 PM ET
$1.85
-$0.04 (-2.12%)
After-hours:
Nov 16, 2026, 7:57 PM ET
Edesa Biotech Company Profile
Company profile explainedCompany Profile
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
Key Executives
| Name | Position |
|---|---|
| Pardeep Nijhawan FRCPC | Chief Executive Officer, Company Secretary & Director |
| Peter John Weiler | Chief Financial Officer |
| Michael J. Brooks | President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2026 | 4 | Filing |
| Oct 23, 2026 | 8-K | Current Report |
| Oct 15, 2026 | 8-K | Current Report |
| Oct 06, 2026 | 4 | Filing |
| Sep 01, 2026 | 4 | Filing |
| Aug 26, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 25, 2026 | SC 13D/A | [Amend] Filing |
| Aug 25, 2026 | SC 13D/A | [Amend] Filing |
| Aug 20, 2026 | 8-K | Current Report |
| Aug 20, 2026 | 424B5 | Filing |
Edesa Biotech
| Country | Canada |
| IPO Date | Jun 21, 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Pardeep Nijhawan |
Stock Details
| Ticker Symbol | EDSA |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001540159 |
| CUSIP Number | 27966L306 |
| ISIN Number | CA27966L3065 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove EDSA